What We're Reading: Page 265
Industry reads hand-picked by our editors
May 11, 2018
-
The Wall Street Journal
Novartis CEO Calls Hiring of Trump Lawyer Michael Cohen a 'Mistake'
-
Vox
The blockbuster fight over this obscure federal program explains America’s drug prices
-
Bloomberg
Former biotech darlings Tesaro, Clovis pin hopes on 2018 rebound
-
CNN
An emotional call to eradicate ancient cousin of HIV
May 10, 2018
May 09, 2018
-
Financial Times
Banks scramble to assemble Asian biotech IPO resources
-
Nikkei Asian Review
Betting the pharma — Japan's misdirected M&A boom
-
The San Diego Union-Tribune
San Diego's Hybritech still influences local biotech, 40 years later
May 08, 2018
May 07, 2018
-
Financial Times
Pharma and healthcare companies brace for Trump shake-up
-
Haaretz
A strong quarter, but Teva’s not yet out of the woods
-
Genetic Engineering & Biotechnology News
25 up and coming gene therapies
-
Chemical & Engineering News
Controlling CAR-T: How scientists plan to make the engineered T cell therapy safer, and work for more cancers
Previous
